A leading specialty pharmaceutical manufacturer, Neuraxpharm, has partnered with Veeva Systems to enhance its quality processes. By utilizing Veeva Vault QualityDocs and Veeva Vault Training, Neuraxpharm aims to improve compliance, oversight, and inspection readiness. The collaboration with Veeva will enable Neuraxpharm to streamline its GxP documentation and quality training on a single platform, making processes more efficient and scalable.
Neuraxpharm, a key player in the central nervous system (CNS) diseases sector, will leverage Veeva’s Vault QualityDocs to facilitate the management of GxP content and information sharing among its network of over 100 contract development and manufacturing organizations (CDMOs). Additionally, Vault Training will enable Neuraxpharm to deliver training and curricula to ensure GxP compliance, ultimately enhancing collaboration with CDMOs and improving overall quality document management.
Sofia Long, Director of Quality Strategy for Europe at Veeva, highlighted the significance of the partnership by emphasizing the importance of streamlining content and training to support Neuraxpharm’s expansion of its product portfolio. By working together, Neuraxpharm and Veeva aim to enhance quality processes across the organization and maintain the production of vital CNS treatments for patients.
For those interested in learning more about Veeva Vault Quality, visit veeva.com/eu/VaultQuality. Stay connected with Veeva on LinkedIn at linkedin.com/company/veeva-systems to keep up with the latest updates and industry news.
Veeva Systems is a global leader in cloud software for the life sciences industry, serving over 1,000 customers worldwide. As a Public Benefit Corporation, Veeva is committed to innovation, product quality, and customer success, aligning the interests of all stakeholders. To learn more about Veeva and its offerings, visit veeva.com/eu.
In conclusion, the partnership between Neuraxpharm and Veeva Systems signifies a step forward in enhancing compliance, oversight, and inspection readiness in the pharmaceutical industry. By leveraging Veeva’s quality applications, Neuraxpharm is poised to improve collaboration with CDMOs and strengthen its quality processes to deliver essential CNS treatments to patients. Visit veeva.com/eu for more information on Veeva’s innovative solutions.
Source link
